Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI
Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI
Recruiting · NCT07231939 · Registry updated 2025-11-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI | Arterial Occlusive Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, kidney disorder, kidney failure, myocardial ischemia, urinary system disorder, vascular disorder | Recruiting | Not stated | 2025-11-17 | NCT07231939 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Collegium Medicum w Bydgoszczy | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Collegium Medicum w Bydgoszczy | Bydgoszcz | Poland | 1 |